guanfacine has been researched along with Obesity in 3 studies
Guanfacine: A centrally acting antihypertensive agent with specificity towards ADRENERGIC ALPHA-2 RECEPTORS.
Obesity: A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Guanfacine was much more effective than yohimbine." | 5.42 | A Comparison of the Anorectic Effect and Safety of the Alpha2-Adrenoceptor Ligands Guanfacine and Yohimbine in Rats with Diet-Induced Obesity. ( Bednarski, M; Dudek, M; Głuch-Lutwin, M; Kazek, G; Knutelska, J; Mordyl, B; Nowiński, L; Pytka, K; Sapa, J; Zygmunt, M, 2015) |
| "Guanfacine was much more effective than yohimbine." | 1.42 | A Comparison of the Anorectic Effect and Safety of the Alpha2-Adrenoceptor Ligands Guanfacine and Yohimbine in Rats with Diet-Induced Obesity. ( Bednarski, M; Dudek, M; Głuch-Lutwin, M; Kazek, G; Knutelska, J; Mordyl, B; Nowiński, L; Pytka, K; Sapa, J; Zygmunt, M, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dudek, M | 1 |
| Knutelska, J | 1 |
| Bednarski, M | 1 |
| Nowiński, L | 1 |
| Zygmunt, M | 1 |
| Mordyl, B | 1 |
| Głuch-Lutwin, M | 1 |
| Kazek, G | 1 |
| Sapa, J | 1 |
| Pytka, K | 1 |
| Potter, PO | 1 |
| John, N | 1 |
| Coffey, DB | 1 |
| Limone, P | 1 |
| Cagliero, E | 1 |
| Massara, F | 1 |
| Molinatti, GM | 1 |
3 other studies available for guanfacine and Obesity
| Article | Year |
|---|---|
A Comparison of the Anorectic Effect and Safety of the Alpha2-Adrenoceptor Ligands Guanfacine and Yohimbine in Rats with Diet-Induced Obesity.
Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-2 Receptor Antagonists; Animals; Appetite Dep | 2015 |
Onset of abnormal movements and cardiovascular symptoms after acute change in complex polypharmacy in a child with attention-deficit/hyperactivity disorder and mood symptoms.
Topics: Adrenergic alpha-Agonists; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Asthma; Attention D | 2012 |
Reduced glucose tolerance after guanfacine in normal and obese subjects.
Topics: Adult; Blood Glucose; Female; Glucose Tolerance Test; Guanfacine; Guanidines; Humans; Insulin; Male; | 1983 |